Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Toxicology
|
December 7, 2007
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines
Elizabeth E Girroir, Holly E Hollingshead, Andrew N Billin, et al.
Plos One
|
March 4, 2014
Human and mouse skeletal muscle stem cells: convergent and divergent mechanisms of myogenesis
Akshay Bareja, Jason A Holt, Guizhen Luo, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2025
Antidiabetic and lipid-lowering medication use inversely linked with serum biomarkers of liver fibrosis
Jun Wang, Dora Ding, Xiaorong Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 4, 2011
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
Janine M Lamonica, Wulan Deng, Stephan Kadauke, et al.
Carcinogenesis
|
August 19, 2007
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines
Holly E Hollingshead, Renee L Killins, Michael G Borland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 18, 2006
Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist
Dennis L Sprecher, Christine Massien, Greg Pearce, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist
Barry G Shearer, David J Steger, James M Way, et al.
Journal of Lipid Research
|
February 3, 2023
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate
Mohamad Dandan, Julia Han, Sabrina Mann, et al.
Clinical Pharmacology and Therapeutics
|
October 8, 2021
Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA
Amy Meng, Rita Humeniuk, Juliane M Jürgensmeier, et al.
ACS Chemical Biology
|
December 24, 2015
Discovery of Novel Small Molecules that Activate Satellite Cell Proliferation and Enhance Repair of Damaged Muscle
Andrew N Billin, Marcus Bantscheff, Gerard Drewes, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Toxicology
|
December 7, 2007
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines
Elizabeth E Girroir, Holly E Hollingshead, Andrew N Billin, et al.
Plos One
|
March 4, 2014
Human and mouse skeletal muscle stem cells: convergent and divergent mechanisms of myogenesis
Akshay Bareja, Jason A Holt, Guizhen Luo, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2025
Antidiabetic and lipid-lowering medication use inversely linked with serum biomarkers of liver fibrosis
Jun Wang, Dora Ding, Xiaorong Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 4, 2011
Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes
Janine M Lamonica, Wulan Deng, Stephan Kadauke, et al.
Carcinogenesis
|
August 19, 2007
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines
Holly E Hollingshead, Renee L Killins, Michael G Borland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 18, 2006
Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist
Dennis L Sprecher, Christine Massien, Greg Pearce, et al.
Molecular Endocrinology (Baltimore, Md.)
|
November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist
Barry G Shearer, David J Steger, James M Way, et al.
Journal of Lipid Research
|
February 3, 2023
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate
Mohamad Dandan, Julia Han, Sabrina Mann, et al.
Clinical Pharmacology and Therapeutics
|
October 8, 2021
Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA
Amy Meng, Rita Humeniuk, Juliane M Jürgensmeier, et al.
ACS Chemical Biology
|
December 24, 2015
Discovery of Novel Small Molecules that Activate Satellite Cell Proliferation and Enhance Repair of Damaged Muscle
Andrew N Billin, Marcus Bantscheff, Gerard Drewes, et al.
Page
of 6